Currently funded projects

Dr. Engeland (MD PhD) and Dr. Veinalde (PhD) discuss results in the research laboratory at the National Center for Tumor Diseases.

Translational research on combination immunotherapy with an oncolytic vaccine

Institution: National Center for Tumor Diseases, German Cancer Research Center, University Hospital Heidelberg
Applicant: Dr. med. Dr. rer. nat. Christine E. Engeland
EKFS funding line: Else Kröner-Memorial-Stipendium

Dr. rer. nat. Verena Boschert (left) and Dr. med. Dr. med. dent. Stefan Hartmann (right) working in the lab of the Department of Oral and Maxillofacial Plastic Surgery (University Hospital Würzburg)

Immune escape mechanisms in head and neck squamous cell carcinoma: The role of HGF/Met signalling pathway

Institution: Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg
Applicant: Stefan Hartmann
EKFS funding line: first application

In vivo high field MRI (left) and ultramicroscopy images (right) of the cleared brain shows the extent of tumor cell infiltration of S24 glioma cells (red). The microvasculature is stained with lectin-FITC (green).

Imaging of immune responses and tumor cell invasion in glioma models

Institution: Universitätsklinik Heidelberg – Deutsches Krebsforschungszentrum
Applicant: Dr. med. Michael Breckwoldt, Ph.D.
EKFS funding line: first application

Research Group Neuroendocrine Tumors (Primary Investigator Dr. S. Nölting)

Characterisation and overcoming mechanisms of resistance to the mTORC1 inhibitor everolimus

Institution: Research Group NeuroendocrineTumors, Department of Internal Medicine IV, University Hospital of Munich, LMU Munich
Applicant: Dr. Svenja Nölting
EKFS fundig line: first application

Das Bild zeigt beteiligte Wissenschaftler und Arbeitsgruppenleiter auf dem Auftaktsymposium 2019 in Mainz.

The role of the diseased hepatic microenvironment for tumor initiation and progression in liver cancer

Institution: Universitätsmedizin Mainz
Applicants: Jens Marquardt, Beate Straub, Hauke Lang
EKFS funding line: Else Kröner-Forschungskolleg

Dr. Maike Busch (links) and PhD student Natalia Miroschnikov (rechts).

Chemotherapy resistances in human retinoblastoma: molecular mechanisms and development of new therapeutic approaches

Institution: University Hospital Essen, Institute of Neuroanatomy
Applicant: Dr. rer. nat. Maike Busch
EKFS funding line: first application

The Else Kröner-Research School Göttingen promotes the career of so-called Clinician Scientists.

Else Kröner Research School “Molecular Therapy and Prediction in Gastrointestinal Malignoma”

Institution: Universitätsmedizin Göttingen, Institut für Molekulare Onkologie
Applicant: Prof. Dr. Matthias Dobbelstein
EKFS funding line: Else Kröner-Forschungskolleg

Liquid Biopsy has evolved as a promising approach for noninvasive cancer detection and monitoring.

Circulating tumor DNA for noninvasive disease profiling and monitoring in patients with primary CNS lymphoma

Applicant: Dr. Florian Scherer
Institution: University Medical Center Freiburg, Department of Hematology, Oncology, and Stem Cell Transplantation
EKFS funding line: first application

Schema zur Entfernung von Tumorzellen durch den programmierten Zelltod (Apoptose) und einiger Faktoren, die dies beeinflussen können.

Therapeutische Nutzung des programmierten Zelltods zur Lungenkrebsbehandlung

Institution: Molekulare Pathologie, Institut für Pathologie & Translationale Genomik,
Uniklinik Köln
Applicant: Dr. med. Johannes Brägelmann
EKFS funding line: Else Kröner-Memorial-Stipendium

Ontogenese der klonalen Hämatopoese

Klonale Hämatopoese: klinische Auswirkungen und funktionelle Konsequenzen im Stammzell-Kompartiment

Institution: Charité – Universitätsmedizin Berlin
Applicant: Frederik Damm
EKFS funding line: Else Kröner-Exzellenzstipendium